Arjo (OM:ARJO B): Exploring Valuation Opportunities After a Quiet Period in Share Price Movement

There has not been a particular event sending shockwaves through Arjo (OM:ARJO B) shares this week, but sometimes a quieter period can be just as interesting. Investors keeping an eye on the medical technology maker may be wondering if recent market movements signal something deeper, such as shifting expectations for growth or profitability. Valuation becomes an important consideration, especially as the company continues to recalibrate in a changing healthcare environment.

Taking a step back, Arjo shares have not had an easy ride. The price is lower compared to a year ago, dropping almost 21% over the past twelve months and down roughly 7% year to date. There have been modest swings in recent months, with only slight growth in the past quarter and a minor dip over the last month. Despite these figures, Arjo’s core numbers show annual revenue and net income growth, which could point to momentum quietly building beneath the surface.

With this mix of steady operational progress and a stock price that has lagged, does Arjo have room to run or have investors already priced in its prospects for future growth?

Advertisement

Most Popular Narrative: 9.6% Undervalued

The prevailing narrative suggests Arjo shares are undervalued by just under 10%, based on expectations that growth catalysts and improving margins will lift future earnings and support a higher share price.

The ongoing demographic shift toward aging populations and increased prevalence of chronic diseases is structurally expanding demand for Arjo's products and services. This underpins long-term revenue growth beyond short-term cycles. Expansion and momentum in rental and service lines are driving stable, recurring revenues and higher margins. These are expected to be further boosted by the shift toward care outside hospitals and more home or community healthcare settings, supporting both margin expansion and earnings stability.

What are the real financial forces powering this valuation call? The story is more than just analyst optimism, with an unexpected set of performance targets and margin forecasts that could change the game for Arjo if realized. Ready to be surprised by what the numbers reveal about Arjo's future?

Result: Fair Value of $37.5 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, ongoing US tariff pressures and sluggish sales in Western Europe could challenge Arjo's momentum. These factors may act as potential headwinds for future growth.

Find out about the key risks to this Arjo narrative.

Another View: What Does Our DCF Model Say?

While analyst price targets point to Arjo being undervalued, our SWS DCF model offers its own perspective. It estimates a fair value based on future cash flows. Does this second look confirm the opportunity, or suggest caution?

Look into how the SWS DCF model arrives at its fair value.

ARJO B Discounted Cash Flow as at Sep 2025
ARJO B Discounted Cash Flow as at Sep 2025

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Arjo for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Arjo Narrative

If you see things differently or like taking a hands-on approach, you can easily build your own perspective in just a few minutes. Do it your way

A great starting point for your Arjo research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.

Looking for More Investment Ideas?

Opportunities do not wait for anyone. If you want your next smart move to count, put these strategies to work using the Simply Wall Street Screener:

  • Capture the potential of up-and-coming markets by browsing penny stocks with strong financials with strong financials and robust growth track records.
  • Tap into the booming world of artificial intelligence by checking out leading-edge AI penny stocks before they become household names.
  • Boost your portfolio’s stability by selecting dividend stocks with yields > 3% offering attractive yields and reliable returns.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About OM:ARJO B

Arjo

Develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific.

Very undervalued with excellent balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7057.9% undervalued
17 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17044.9% undervalued
36 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative
FU
ONTO logo
FundamentalFlow on Onto Innovation ·

Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Fair Value:US$38033.4% undervalued
25 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7447.4% undervalued
57 users have followed this narrative
0 users have commented on this narrative
15 users have liked this narrative

Updated Narratives

HA
Harshvardhan
IOC logo
Harshvardhan on Indian Oil ·

INDIAN OIL CORPORATION IS THE TITAN IN TRANSITION

Fair Value:₹21435.4% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
HA
Harshvardhan
VEDL logo
Harshvardhan on Vedanta ·

VEDANTA LTD (POST-DEMERGER) THE BULL CASE

Fair Value:₹37515.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CH
NEE logo
ChuckN on NextEra Energy ·

Investor Thesis: Why the NextEra Energy / Dominion Energy Merger Could Be a Major AI Power Infrastructure Event

Fair Value:US$93.718.4% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7447.4% undervalued
57 users have followed this narrative
0 users have commented on this narrative
15 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9722.6% undervalued
57 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1933.2% undervalued
47 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative